MedTrace Logo

The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States

NCT03952364 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-10-14

No results posted yet for this study

Summary

A multi-center observational study based at referral centers and community hospitals within the US. Patients' blood will be collected at enrollment for testing with PredictSURE IBD™, which will occur at a later date. Patients will be prospectively followed up for 12 months with clinicians treating according to local standard of care, with a step-up or accelerated step-up regimen. Clinicians and patients will be blinded to the biomarker results.

Conditions

Interventions

OTHER

PredictSURE IBD™

To evaluate a test called PredictSURE IBD™ in the US population

Sponsors & Collaborators

  • Crohn's and Colitis Foundation

    collaborator OTHER

  • PredictImmune Ltd

    lead INDUSTRY

Principal Investigators

  • James Lee, MD · PredictImmune Ltd

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03952364 on ClinicalTrials.gov